Wegovy 0.25 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FC66M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,122
Award facts
- Contract value 100% obligated
- $13,121.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Wegovy (semaglutide) 0.25 mg/0.5 mL pen injections, with a contract value of $13,121.52 and an ultimate completion date of August 6, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded on August 5, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order transaction under the company's existing indefinite delivery contract vehicle with DLA.
This delivery order is issued under AmerisourceBergen Drug Corp's SPE2DX Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support agreement valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a broad range of pharmaceutical products and medical commodities to support military healthcare programs and other government healthcare systems. The Wegovy delivery fulfills pharmaceutical supply needs for the Defense Health Agency and other authorized federal customers through this flexible contract vehicle, which enables AmerisourceBergen to provide both brand-name and generic medications across multiple therapeutic domains to support defense and veteran healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FC66M?
SPE2DB25FC66M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 5, 2025.
How much is contract SPE2DB25FC66M worth?
The government has obligated $13,122 on SPE2DB25FC66M.
Is contract SPE2DB25FC66M an order under another contract?
Yes. SPE2DB25FC66M is a delivery order under SPE2DB20D2014, an indefinite delivery contract.
Was contract SPE2DB25FC66M competed?
The extent of competition for SPE2DB25FC66M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award